Three Names Proposed For Position Of Biological Drugs Analyst

Ministry Of National Health Services & Regulations Has Proposed Names Of 3 Pharmacists For Position Of Biological Drugs Analyst.

Three Names Proposed For Position Of Biological Drugs Analyst

Sources said that the ministry has proposed Chief Pharmacist Amna Bibi, Drug Regulatory Authority Of Pakistan (DRAP) Deputy Director Muhammad Arif Chaudhry and DRAP Deputy Director Zeeshan Nazir for this position.

The Drug Act, 1976, was promulgated to regulate the import, export, manufacture storage, distribution, and sale of drugs.

The fact that many vaccines and biological products, imported and produced locally, require the certificate of the federal government analyst has necessitated the appointment of a biological drugs analyst. As per schedule of the Drug Regulatory Authority of Pakistan Act, 2012, biological drugs are not allowed for sale and use until a “Lot Release Certificate” from the federal government analyst has been obtained.

This analyst would head the National Control Laboratory for Biological (NCLB), Islamabad, and report to the DRAP director.

The previous drug analyst was appointed for a period of three months, and their tenure expired in June 2020. Nominations from different hospitals institutions were sought and the abovementioned people have been proposed.

PCSIR CHAIRMAN:

Meanwhile, the Ministry of Science and Technology has proposed names of Syed Hussain Abidi, Professor Arshad Saleem Bhatti and Dr Syed Habib Bukhari for the position of chairman for Pakistan Council of Scientific and Industrial Research (PCSIR).

The ministry had advertised this post and eventually received 55 applications.

The selection board under the chair of Federal Minister for Science and Technology conducted 15 interviews and the board recommended the above for the post.

This news was originally published at pakistantoday.com.pk